Drugs / RTS,S/AS01
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04319380 Comparator | Apr 2020 → Mar 2022 | Plasmodium falciparum malaria | London School of Hygiene and Tropical Medicine | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RTS,S/AS01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04319380 ↗ |
| Modality | Vaccine | “The RTS,S/AS01 malaria vaccine is a recombinant protein vaccine” NCT04319380 ↗ |